Eubel Brady & Suttman Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.8M | Buy |
71,726
+904
| +1% | +$237K | 2.38% | 21 |
|
2025
Q1 | $16.5M | Buy |
+70,822
| New | +$16.5M | 2.17% | 20 |
|
2024
Q2 | – | Sell |
-110,650
| Closed | -$24.2M | – | 98 |
|
2024
Q1 | $24.2M | Buy |
110,650
+43,369
| +64% | +$9.47M | 3.08% | 11 |
|
2023
Q4 | $15.3M | Buy |
67,281
+892
| +1% | +$203K | 2.03% | 26 |
|
2023
Q3 | $13.3M | Sell |
66,389
-3,875
| -6% | -$779K | 1.95% | 27 |
|
2023
Q2 | $14.6M | Buy |
70,264
+1,498
| +2% | +$311K | 2.01% | 26 |
|
2023
Q1 | $13.6M | Buy |
68,766
+2,318
| +3% | +$457K | 1.97% | 25 |
|
2022
Q4 | $13.4M | Buy |
66,448
+1,493
| +2% | +$302K | 2.16% | 21 |
|
2022
Q3 | $11.4M | Buy |
64,955
+3,810
| +6% | +$670K | 2.04% | 24 |
|
2022
Q2 | $12.3M | Buy |
61,145
+1,730
| +3% | +$348K | 2.46% | 22 |
|
2022
Q1 | $13.5M | Buy |
59,415
+1,723
| +3% | +$390K | 2.47% | 20 |
|
2021
Q4 | $15.6M | Buy |
57,692
+392
| +0.7% | +$106K | 3.05% | 15 |
|
2021
Q3 | $13.9M | Sell |
57,300
-1,065
| -2% | -$257K | 2.88% | 19 |
|
2021
Q2 | $12.8M | Sell |
58,365
-58,366
| -50% | -$12.8M | 1.12% | 23 |
|
2021
Q1 | $25.6M | Buy |
116,731
+54,806
| +89% | +$12M | 2.79% | 20 |
|
2020
Q4 | $10.8M | Sell |
61,925
-1,892
| -3% | -$331K | 2.6% | 20 |
|
2020
Q3 | $10.3M | Buy |
63,817
+151
| +0.2% | +$24.4K | 2.75% | 18 |
|
2020
Q2 | $9.09M | Sell |
63,666
-310
| -0.5% | -$44.2K | 2.39% | 23 |
|
2020
Q1 | $6.95M | Buy |
+63,976
| New | +$6.95M | 2.08% | 25 |
|